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Purpose.T oe s t i m a t ee ﬀective dose and organ equivalent doses of prospective ECG-triggered high-pitch CTCA. Materials and
Methods. For dose measurements, an Alderson-Rando phantom equipped with thermoluminescent dosimeters was used. The
eﬀective dose was calculated according to ICRP 103. Exposure was performed on a second-generation dual-source scanner
(SOMATOM Deﬁnition Flash, Siemens Medical Solutions, Germany). The following scan parameters were used: 320mAs per
rotation, 100 and 120kV, pitch 3.4 for prospectively ECG-triggered high-pitch CTCA, scan range of 13.5cm, collimation
64 × 2 × 0.6mm with z-ﬂying focal spot, gantry rotation time 280ms, and simulated heart rate of 60 beats per minute. Results.
Depending on the applied tube potential, the eﬀective whole-body dose of the cardiac scan ranged from 1.1mSv to 1.6mSv and
from 1.2 to 1.8mSv for males and females, respectively. The radiosensitive breast tissue in the range of the primary beam caused an
increasedfemale-speciﬁceﬀectivedoseof8.6%±0.3%comparedtomales.Decreasingthetubepotential,asigniﬁcantreductionof
the eﬀective dose of 35.8% and 36.0% can be achieved for males and females, respectively (P<0.001). Conclusion. The radiologist
and the CT technician should be aware of this new dose-saving strategy to keep the radiation exposure as low as reasonablly
achievable.
1.Introduction
At present, computed tomography coronary angiography
(CTCA) is an important, widely accepted diagnostic tool for
the assessment of coronary artery disease. Several studies
have shown the potential of diﬀerent dose-saving strate-
gies to keep the radiation exposure as low as reasonablly
achievable. Hausleiter et al. reported in an international
multicenter trial (PROTECTION I) a mean eﬀective dose of
12mSv in CTCA, ranging from 5 to 30mSv [1]. Radiation
exposure can be reduced substantially by currently available
strategies, but these possibilities are used infrequently [1].
Since the introduction of a second-generation dual-
source scanner system, a new scanning mode with increased
table feed is available. Compared to retrospective ECG-
gated and prospective ECG-triggered CTCA, this high-
pitch, prospective triggered scanning mode has the potential
for drastic dose reduction due to a gapless imaging of
the heart within one heartbeat with no overlapping data
acquisition.2 Radiology Research and Practice
The aim of the study was to estimate eﬀective whole-
body dose and organ equivalent doses of prospective ECG-
triggered high-pitch CTCA.
2.MaterialandMethods
2.1. Dosimetry. The experiments were performed by using
an anthropomorphic, hermaphrodite male phantom with
breast phantom attachments (Alderson-Rando phantom;
Alderson Research Laboratories Inc., Stanford, CT, USA).
The phantom was equipped with 117 thermoluminescent
dosimeters (TLDs) with dimension of 1 × 1 × 6mm (TLD-
100H, Bicon-Harshow, Radiation Measurement Products,
Cleveland, OH, USA) to perform radiation exposure mea-
surements [2–4].
By using a Philips Optimus 65 (Philips Medical Systems,
PC Best, The Netherlands), a calibration of the 117 was
calculated, which was deﬁned by means of parallel exposure
of 33 TLDs with a known radiation dose using 102kV
and 10mA for 100ms at a source-skin distance (SSD) of
100cm. To minimize the Heel eﬀect, wire markers in the
ﬁeld were avoided and all expositions were done in the same
position with respect to the orientation of the X-ray tube.
Crosschecked by an ionization dosimeter positioned in the
samephantomdepths,thereferenceTLDswereexposedwith
a dose of 1.081mGy. No further correction factors were used
as the calibration voltage is close to the CT tube voltage.
The evaluation of the irradiated TLDs was performed
using a TLD reader (Model 5500 TLD Reader, Bicron
Radiation Measurement Products, Solon, OH, USA) within
24h after radiation exposure. The readout TLD values in
nanocoulombs were multiplied by an individual calibration
factor.
Dependent on the anatomical position of each organ
39 diﬀerent positions in the Alderson-Rando Phantom
were used to assess the organ doses. Due to measurement
deviation, three TLDs were placed at each point of dose mea-
surement to minimize bias. The number of TLDs allocated
to diﬀerent organ positions were as follows: 3 at the brain,
thyroid gland, esophagus, thymus, heart, breast, stomach,
upper colon, spleen, kidneys, adrenal glands, pancreas, small
intestine, lower colon, urinary bladder, muscle tissue, red
bone marrow, skin, ovaries, and testicles, 42 at the lung, and
15 at the liver.
The eﬀective dose was calculated by summarizing the
weighted organ doses according to the guidelines of ICRP
103 [5]. Radiation doses of simulated small organs (i.e.,
thyroid gland) were directly rated into the calculation. Doses
of larger organs (i.e., lung) were determined by assessing the
mean of measured TLDs from the entire organ.
To assess gender-speciﬁc diﬀerences, the testicles were
used to measure the male-speciﬁc gonadal dose while
radiation dose of the breast and the ovaries accounted to
the female-speciﬁc radiation exposure. The breast phantom
attachments could inﬂuence the calculation of the male-
speciﬁc eﬀective dose by increased soft tissue in the scan
range. Nevertheless, evaluated values of eﬀective dose using a
hermaphrodite phantom are suﬃciently precise for applica-
tion in radiological radiation protection [5, 6].
2.2. Scan Protocols. Scans were performed on a second-
generation dual-source CT scanner (SOMATOM Deﬁnition
Flash, Siemens Medical Solutions, Forchheim, Germany).
The following parameters were used: 320mAs per rotation,
100 and 120kV, pitch 3.4 for prospectively ECG-triggered
CTCA (table feed 450mm/s), scan range of 13.5cm (four
blocks of sequential detector coverage), collimation 64 × 2 ×
0.6mm with z-ﬂying focal spot, and gantry rotation time
280ms. The scanner software simulated a heart rate of 60
beats per minute. 60% of the RR-interval was set to trigger
the scan. In high-pitch CTCA, the heart is scanned within
one heartbeat. Data acquisition with two X-ray tubes and
detectors allows a gapless imaging of the heart despite a high
pitch of 3.4. Gaps in the data from the ﬁrst measurement
system resulting from the high pitch are ﬁlled completely
with the data from the second measurement system that
acquires the data a quarter rotation later [7].
2.3. Statistical Analysis. Normal distribution of measured
organ-speciﬁc dose values of each scan protocol was assessed
using the Kolmogorov-Smirnov test. Statistical signiﬁcance
between diﬀerent scan protocols was evaluated using the
two-tailed paired Student’s t-test comparing the measured
organ-speciﬁc dose values. A P value <0.05 was considered
to be signiﬁcant.
3. Results
Eﬀective, gender-speciﬁc doses of scan protocols with 100kV
and 120kV and reported CT dose index and dose length
product are shown in Table 1.
Depending on the applied tube potential, the eﬀective
whole-body dose of the cardiac scan ranged from 1.1mSv
to 1.6mSv and from 1.2 to 1.8mSv for males and females,
respectively.
Directly irradiated organs within the scan range received
organ equivalent doses of up to 0.33mSv to the lung and up
to 0.13mSv to the breast. The radiosensitive breast tissue in
the range of the primary beam caused an increased female-
speciﬁc eﬀective dose of 8.6% ± 0.3% compared to males.
The gonadal doses were <0.02mSv in both scan protocols.
DetailsaboutorganequivalentdosesaredisplayedinTable 2.
A reduction of the tube potential from 120kV to 100kV
signiﬁcantly reduces the radiation exposure by 35.8% for
males and 36.0% for females, respectively (P<0.001).
4. Discussion
Several studies described the correlation between the pitch
value and the radiation exposure in computed tomography
coronary artery (CTCA). Typically, the pitch is less than
1, usually between 0.2 and 0.5 in ﬁrst-generation dual-
source CTCA resulting in relevant overlaps by advancing
the table much less than one detector width during one
scanner rotation [3, 7]. Thus, repeated exposure of the same
heart region during several consecutive rotations causes an
increase of radiation exposure.
The evaluated, prospective ECG-triggered high-pitch
CTCA uses a pitch value of 3.4 resulting in a table feed ofRadiology Research and Practice 3
Table 1: Eﬀective radiation exposure of high-pitch CTCA using 100kV and 120kV.
Protocol Eﬀective dose
male [mSv]
Eﬀective dose
female [mSv] Total mAs CTDIVol (mGy) DLP (mGycm)
1 (100kV) 1.1 1.2 688 3.1 56
2 (120kV) 1.6 1.8 689 5.2 95
CTDIVol: volume CT dose index; DLP: dose-length product.
Table 2: Measured organ equivalent doses of high-pitch CTCA
using diﬀerent tube voltages (mSv).
Organ/tissue 100kV 120kV
Thyroid gland 0.03 0.04
Esophagus 0.05 0.05
Lung 0.20 0.33
Breast 0.07 0.13
Stomach 0.45 0.67
Liver 0.06 0.12
Colon 0.03 0.03
Urinary bladder 0.00 0.00
Red bone marrow 0.01 0.02
Skeleton 0.00 0.00
Skin 0.00 0.01
Male gonads 0.00 0.00
Female gonads 0.01 0.01
Remaining organs 0.22 0.37
450mm/s with no overlapping data acquisition by ﬁlling
the gaps in the data of the spiral acquisition of the ﬁrst
measurement system with the data from the second mea-
surement system one-quarter rotation later. The whole heart
is completely scanned within one heart cycle, that is, the
topmost image will be acquired at the set trigger point and
subsequent images display the heart in later phases of the
heart cycle [8–11].
In this study, we determined the eﬀective radiation
exposure of prospective ECG-triggered high-pitch CTCA
depending on the gender and the used tube voltage. The
results are concordant to recently reported dose values from
Goettietal.[8].Theradiationexposureissubstantiallylower
than other reported dose values of retrospective ECG-gated
or prospective ECG-triggered CTCA. A comparative study
of diﬀerent dose-saving techniques reports eﬀective dose
values of 5.8mSv to 16.0mSv for retrospective ECG-gated
protocols without ECG-pulsing, and 4.2mSv to 9.8mSv
for protocols with diﬀerent ECG-pulsing techniques and
2.8mSv to 4.3mSv for prospective ECG-triggered, the so-
called step-and-shoot, CTCA [12].
A further radiation protective eﬀect comprises the acqui-
sition of less overlapping data. This results in reduction of
the organ equivalent dose of the extremely radiosensitive
female breast tissue, which is always in the scan range, but
rarely organ of interest. In high-pitch CTCA, the female-
speciﬁc eﬀective dose is higher compared to male eﬀective
dose measurements by an average of up to 8.6%. In conven-
tional overlapping CTCA data acquisition, however, females
received increased eﬀective dose values of up to 70% [6, 12–
14].
By decreasing the tube voltage, the eﬀective dose can be
further reduced by up to 36.0% in high-pitch CTCA. How-
ever, changes in tube voltage are complex and aﬀect image
noise as well as tissue contrast. Nevertheless, several studies
conﬁrmed a suﬃcient image quality of 100kV CTCA proto-
cols in slender patients with a body mass index lower than
30kg/m2 [15].
A possible limitation of the study is the lack to determine
image quality as an additional parameter of the technique.
However, initial feasibility studies reported an excellent
image quality in a selected patient population [9, 15]. High-
pitch CTCA shows equivalent image quality in patients
with low and stable heart rates up to 60bpm compared
to prospective ECG-triggered and retrospective ECG-gated
CTCA. A diagnostic image quality can be achieved in 97%
of coronary segments with high-pitch CTCA [16–18]. These
studies recommend this prospective, R-wave triggered, high-
pitch scanning mode for patients with low and regular heart
rates (<55–60 beats per minute) to acquire the complete
dataset before the onset of atrial contraction [7, 9, 10].
5. Conclusion
In conclusion, the prospective ECG-triggered high-pitch
CTCA has the potential to scan the heart with an eﬀective
dose between 1mSv and 2mSv, which is substantially lower
than previously described CTCA scanning modes. The
radiologist and the CT technician should be aware of this
new dose-saving strategy to keep the radiation exposure as
low as reasonablly achievable.
Disclosure
B.SchmidtandT.G.FlohrareemployeesofSiemensMedical
Solutions.
References
[1] J. Hausleiter, T. Meyer, F. Hermann et al., “Estimated radiation
dose associated with cardiac CT angiography,” Journal of the
American Medical Association, vol. 301, no. 5, pp. 500–507,
2009.4 Radiology Research and Practice
[2] D. Ketelsen, M. H. Luetkhoﬀ, C. Thomas et al., “Estimation of
the radiation exposure of a chest pain protocol with ECG-
gating in dual-source computed tomography,” European Radi-
ology, vol. 19, no. 1, pp. 37–41, 2009.
[3] D. Ketelsen, C. Thomas, M. Werner et al., “Dual-source
computed tomography: estimation of radiation exposure
of ECG-gated and ECG-triggered coronary angiography,”
European Journal of Radiology, vol. 73, no. 2, pp. 274–279,
2010.
[4] P.Hunold,F.M.Vogt,A.Schmermundetal.,“Radiationexpo-
sure during cardiac CT: eﬀective doses at multi-detector row
CTandelectron-beamCT,”Radiology,vol.226,no.1,pp.145–
152, 2003.
[5] “The 2007 recommendations of the international commission
on radiological protection,” Annals of the ICRP, vol. 37, no. 2–
4, pp. 1–332, 2007, ICRP publication 103.
[6] H. Von Boetticher, J. Lachmund, H. K. Looe, W. Hoﬀmann,
and B. Poppe, “2007 Recommendations of the ICRP change
basis for estimation of the eﬀective dose: what is the impact
on radiation dose assessment of patient and personnel?”
RoFo Fortschritte auf dem Gebiet der Rontgenstrahlen und der
Bildgebenden Verfahren, vol. 180, no. 5, pp. 391–395, 2008.
[7] S. Achenbach, M. Marwan, T. Schepis et al., “High-pitch spiral
acquisition: a new scan mode for coronary CT angiography,”
Journal of Cardiovascular Computed Tomography, vol. 3, no. 2,
pp. 117–121, 2009.
[8] R. Goetti, S. Leschka, M. Boschung et al., “Radiation doses
from phantom measurements at high-pitch dual-source com-
puted tomography coronary angiography,” European Journal
of Radiology, vol. 81, no. 4, pp. 773–779, 2012.
[9] M. Lell, M. Marwan, T. Schepis et al., “Prospectively ECG-
triggered high-pitch spiral acquisition for coronary CT
angiography using dual source CT: technique and initial expe-
rience,” European Radiology, vol. 19, no. 11, pp. 2576–2583,
2009.
[10] T. G. Flohr, E. Klotz, T. Allmendinger, R. Raupach, H. Bruder,
and B. Schmidt, “Pushing the envelope: new computed to-
mography techniques for cardiothoracic imaging,” Journal of
Thoracic Imaging, vol. 25, no. 2, pp. 100–111, 2010.
[11] T. G. Flohr, S. Leng, L. Yu et al., “Dual-source spiral CT with
pitch up to 3.2 and 75ms temporal resolution: image recon-
struction and assessment of image quality,” Medical Physics,
vol. 36, no. 12, pp. 5641–5653, 2009.
[12] D. Ketelsen, M. Fenchel, M. Buchgeister et al., “Estimation of
radiation exposure of diﬀerent dose saving techniques in 128-
slice computed tomography coronary angiography,” European
Journal of Radiology, vol. 81, no. 2, pp. e153–e157, 2012.
[13] L. W. Poll, M. Cohnen, S. Brachten, K. Ewen, and U. M¨ odder,
“Dose reduction in multi-slice CT of the heart by use of
ECG-controlled tube current modulation (“ECG pulsing”):
phantom measurements,” RoFo Fortschritte auf dem Gebiet der
Rontgenstrahlen und der Bildgebenden Verfahren, vol. 174, no.
12, pp. 1500–1505, 2002.
[14] T. Trabold, M. Buchgeister, A. Kuttner et al., “Estimation of
radiation exposure in 16-detector row computed tomography
of the heart with retrospective ECG-gating,” RoFo Fortschritte
auf dem Gebiet der Rontgenstrahlen und der Bildgebenden Ver-
fahren, vol. 175, no. 8, pp. 1051–1055, 2003.
[15] S.Leschka,P.Stolzmann,L.Desbiollesetal.,“Diagnosticaccu-
racy of high-pitch dual-source CT for the assessment of coro-
nary stenoses: ﬁrst experience,” European Radiology, vol. 19,
no. 12, pp. 2896–2903, 2009.
[ 1 6 ]J .R .G h a d r i ,S .M .K u e s t ,R .G o e t t ie ta l . ,“ I m a g eq u a l i t ya n d
radiation dose comparisonof prospectively triggered low-dose
CCTA: 128-slice dual-source high-pitch spiral versus 64-
slice single-source sequential acquisition,” The International
Journal of Cardiovascular Imaging. In press.
[17] L. A. Neefjes, A. S. Dharampal, A. Rossi et al., “Image quality
and radiation exposure using diﬀerent low-dose scan proto-
cols in dual-source CT coronary angiography: randomized
study,” Radiology, vol. 261, no. 3, pp. 779–786, 2011.
[18] P.Stolzmann,R.P.Goetti,P.Maurovich-Horvatetal.,“Predic-
tors of image quality in high-pitch coronary CT angiography,”
American Journal of Roentgenology, vol. 197, no. 4, pp. 851–
858, 2011.